You are here

  • Home
  • Archive
  • Volume 13, Issue 2
  • Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study

Article info

Article menu
Download PDFPDF
Original Articles
Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study

Authors

  1. Address correspondence and reprint requests to: Thomas Bauknecht, Lilly Deutschland GmbH, Saalburgstr. 153, 61350 Bad Homburg, Germany. Email: Bauknecht_Thomas{at}Lilly.com.

Citation

Bauknecht T, Hefti A, Morack G, et al
Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study
International Journal of Gynecologic Cancer 2003;13:130-137.

Publication history

  • First published February 1, 2003.
Online issue publication 
March 06, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2003 Blackwell Science Ltd.